Install
Cell & Gene Therapies
CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up.
- 4 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Cell & Gene Therapies
CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
2+ day, 1+ hour ago (60+ words) CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies openPR.com CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Press release from: ABNewswire Permanent link to this press release: You can edit or delete your…...
CRISPR Activation Tool Uncovers Genes Linked to Lymphoma Drug Resistance
2+ day, 3+ min ago (505+ words) Inside Precision Medicine A new whole-genome CRISPR screening platform has helped researchers identify a previously unknown gene causing lymphoma cells to become resistant to a widely used cancer drug, as well as several genes that can accelerate tumor growth. Published…...
Christ Hospital trial targets genetic fix for high cholesterol
1+ day, 20+ hour ago (21+ words) WCPO 9 News Christ Hospital trial targets genetic fix for high cholesterol...
Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool
1+ day, 23+ hour ago (437+ words) Researchers used a powerful new guide RNA library, Partita, to find genes that help lymphoma cells escape treatment and accelerate tumor growth image: L-R: Dr Eddie La Marca, Prof Marco Herold; L-R: Dr Yexuan Deng, Dr Margaret Potts, Dr Sarah…...
CRISPR Tool Unveils Gene Behind Blood Cancer Drug Resistance
1+ day, 23+ hour ago (338+ words) GLOBAL: Researchers have uncovered a previously unknown gene causing resistance to a leading blood cancer drug and several genes that accelerate lymphoma growth by using a powerful new CRISPR activation library. Traditional CRISPR is a genetic engineering tool that allows…...
iPSC-derived CAR γδ T cells for liver cancer
2+ day, 6+ hour ago (374+ words) Autologous chimeric antigen receptor (CAR) T cell therapies are now a part of standard treatment protocol for hematological malignancies. Despite this, they are deeply constrained by elevated costs and delayed access for patients. Allogeneic donor-derived CAR T cells make off-the-shelf…...
Study shows reprogramming thyroid tumors may improve CAR-T cell therapy
2+ day, 7+ hour ago (592+ words) ROCHESTER, Minn. — Mayo Clinic researchers have identified a strategy that could help chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, overcome a major barrier to treating solid tumors: Cancer cells can change in ways that allow them to hide…...
The Fratricide Problem: Why CAR-T Struggled Against T-Cell Cancers, and How Scientists Are Finally…
2+ day, 20+ hour ago (136+ words) The Fratricide Problem: Why CAR-T Struggled Against T-Cell Cancers, and How Scientists Are Finally Solving It When the Cure and the Cancer Look the Same CAR-T cell therapy has quietly become one of …...
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market Set for Strong Growth Through 2036, Driven by Next-Generation Innovation and Expanding Patient Access
4+ day, 15+ hour ago (442+ words) ALL care is shifting toward CAR-T, creating opportunities in earlier treatment, off-the-shelf platforms and CD7 targeting, while relapse, toxicity and manufacturing remain key unmet needs. Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Market Insight, Epidemiology, and Market…...
IASO Bio's CD20-Targeted In Vivo CAR-T Therapy IASO208 Receives FDA IND Clearance
4+ day, 7+ hour ago (110+ words) Sep 16, 2026, 05:47 ET — IASO208 is the first China-originated lentiviral vector-based in vivo CAR-T therapy to receive FDA IND clearance — Supported by early clinical data from an investigator-initiated trial in China, IASO208 is expected to advance directly into a Phase 1b clinical study in the…...